Pineapple Express Cannabis (PNXP) Total Liabilities (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Total Liabilities came in at $8.3 million in Q4 2025, up 179.24% year-on-year from $3.0 million in Q4 2024, and little changed quarter-over-quarter from $8.4 million in Q3 2025.
Pineapple Express Cannabis (PNXP) Total Liabilities (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Total Liabilities across 8 years of filings, most recently posting $8.3 million for Q4 2025.
- Total Liabilities for Q4 2025 came in at $8.3 million, up 179.24% year-over-year; the trailing twelve-month figure through Oct 2025 was $8.3 million (up 179.24% YoY), and the FY2025 annual result was $2079.0, down 88.32% from the prior year.
- Total Liabilities came in at $8.3 million for Q4 2025 at Pineapple Express Cannabis, roughly flat from $8.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $8.4 million in Q2 2025 to a low of $2079.0 in Q1 2025.
- The 5-year median for Total Liabilities is $76944.0 (2022), against an average of $1.9 million.
- Peak annual rise in Total Liabilities reached 25828.29% in 2024, while the deepest fall reached 96.74% in 2024.
- Pineapple Express Cannabis' Total Liabilities stood at $72015.0 in 2021, then increased by 11.37% to $80200.0 in 2022, then plunged by 80.46% to $15669.0 in 2023, then soared by 18970.76% to $3.0 million in 2024, then surged by 179.24% to $8.3 million in 2025.
- The last three Total Liabilities figures came in at $8.3 million (Q4 2025), $8.4 million (Q3 2025), and $8.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Pineapple Express Cannabis | - | - | - | 8.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 8.34 Mn |
| Jul 31, 2025 | 8.37 Mn |
| Apr 30, 2025 | 8.40 Mn |
| Jan 31, 2025 | 2,079.00 |
| Oct 31, 2024 | 2.99 Mn |
| Jul 31, 2024 | 2.98 Mn |
| Apr 30, 2024 | 4.98 Mn |
| Jan 31, 2024 | 17,797.00 |
| Oct 31, 2023 | 15,669.00 |
| Jul 31, 2023 | 15,670.00 |
| Apr 30, 2023 | 19,200.00 |
| Jan 31, 2023 | 546,650.00 |
| Oct 31, 2022 | 80,200.00 |
| Jul 31, 2022 | 77,002.00 |
| Apr 30, 2022 | 76,886.00 |
| Jan 31, 2022 | 77,114.00 |
| Oct 31, 2021 | 72,015.00 |
| Jul 31, 2021 | 72,015.00 |
| Apr 30, 2021 | 53,765.00 |
| Jan 31, 2021 | 48,235.00 |